News
TELA
0.7306
+3.54%
0.0250
Weekly Report: what happened at TELA last week (0622-0626)?
Weekly Report · 13h ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 4d ago
Weekly Report: what happened at TELA last week (0615-0619)?
Weekly Report · 06/22 09:20
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 06/16 21:06
Weekly Report: what happened at TELA last week (0608-0612)?
Weekly Report · 06/15 09:19
TELA Bio director Guido Neels files initial beneficial ownership statement
PUBT · 06/11 22:08
TELA Bio director Paul Thomas files initial beneficial ownership statement
PUBT · 06/11 22:07
TELA Bio director Guy P. Nohra files initial beneficial ownership statement
PUBT · 06/11 22:05
TELA Bio Shareholders Expand Equity Incentive Plan Authorization
TipRanks · 06/11 21:03
TELA Bio shareholders approve 3.5 million-share increase to equity incentive plan
PUBT · 06/11 20:07
Weekly Report: what happened at TELA last week (0601-0605)?
Weekly Report · 06/08 09:19
Weekly Report: what happened at TELA last week (0525-0529)?
Weekly Report · 06/01 09:20
Weekly Report: what happened at TELA last week (0518-0522)?
Weekly Report · 05/25 09:21
Tela Bio Eyes Second-Half Ramp After Mixed Quarter
TipRanks · 05/20 07:53
Weekly Report: what happened at TELA last week (0511-0515)?
Weekly Report · 05/18 09:20
Tela Bio Earnings Call Balances Momentum and Risk
TipRanks · 05/14 00:11
Lake Street Keeps Their Buy Rating on TELA Bio (TELA)
TipRanks · 05/13 13:37
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), UnitedHealth (UNH) and TELA Bio (TELA)
TipRanks · 05/13 13:10
Analysts Conflicted on These Healthcare Names: TELA Bio (TELA), Rezolute (RZLT) and Legend Biotech (LEGN)
TipRanks · 05/13 11:10
TELA outlines at least 8% 2026 revenue growth while guiding Q2 revenue to about $20.0M
Seeking Alpha · 05/13 00:52
More
Webull provides a variety of real-time TELA stock news. You can receive the latest news about Tela Bio, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About TELA
TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.